Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The price of Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC) closed at $0.34 in the last session, down -17.25% from day before closing price of $0.41. In other words, the price has decreased by -$17.25 from its previous closing price. On the day, 2.29 million shares were traded.
Ratios:
We take a closer look at CYCC’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 5.60 and its Current Ratio is at 5.60. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 26 ’25 when Lazar David E. sold 194,628,820 shares for $0.03 per share. The transaction valued at 5,507,996 led to the insider holds 0 shares of the business.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 759.62 while its Price-to-Book (P/B) ratio in mrq is 1.44.
Stock Price History:
Over the past 52 weeks, CYCC has reached a high of $39.84, while it has fallen to a 52-week low of $0.25. The 50-Day Moving Average of the stock is -87.40%, while the 200-Day Moving Average is calculated to be -95.29%.
Shares Statistics:
A total of 22.27M shares are outstanding, with a floating share count of 22.27M. Insiders hold about 0.00% of the company’s shares, while institutions hold 0.46% stake in the company.
